GSK Consumer Healthcare Announces the Return of Alli to Retail Stores
GlaxoSmithKline (GSK) Consumer Healthcare has announced the return of alli (orlistat 60 mg capsules) to most stores in the US and Puerto Rico since the voluntary retail recall of the product last spring. Replenished supplies of alli feature improved tamper-evident packaging. alli is the only FDA approved over-the-counter weight loss aid clinically proven to help boost weight loss efforts.
In March 2014, GSK Consumer Healthcare issued a voluntary retail recall of alli when it determined some packages did not contain authentic alli capsules. The Company's review concluded product tampering occurred after the affected product was shipped to retail outlets. GSK Consumer Healthcare continues to support the FDA's Office of Criminal Investigations on their tampering investigation.
"Nothing is more important than the health and safety of those who use our products. The alli product will now feature additional tamper-evident packaging. It's part of GSK Consumer Healthcare's continued commitment to ensure the safety and quality of our products," said Colin Mackenzie, president of GSK Consumer Healthcare North America. "We regret the inconvenience caused for our consumers and retailers, and we are very grateful for their patience as we worked diligently to bring alli back to market."
"We are thankful for the continued outpouring of support for our alli brand, and the great interest to learn when it will return to shelf," said Dennis Sabo, marketing director for alli. "We are pleased to get alli® back into the hands of our loyal consumers, many of whom have contacted us over the last year to express their loyalty to the brand and interest in being able to purchase it again."
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance